Status: current, Defined. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3452781000168110 | buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 28 tablets (medicinal product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3452791000168113 | buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 28 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 28 | Is a | medicinal product pack | true | Inferred relationship | Some | ||
| buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 28 | has MPUU | buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Buprenorphine/Naloxone 11.4/2.9 (MPL) sublingual tablet, 28 | Is a | True | buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 28 | Inferred relationship | Some | |
| Zubsolv 11.4/2.9 sublingual tablet, 28 | Is a | True | buprenorphine 11.4 mg + naloxone 2.9 mg sublingual tablet, 28 | Inferred relationship | Some |
Reference Sets
Schedule 8 medications reference set
List of Medicines for Brand Consideration reference set
Medicinal product pack reference set
FHIR